Cargando…
Lung fibrosis: Post-COVID-19 complications and evidences
BACKGROUND: COVID 19, a lethal viral outbreak that devastated lives and the economy across the globe witnessed non-compensable respiratory illnesses in patients. As been evaluated in reports, patients receiving long-term treatment are more prone to acquire Pulmonary Fibrosis (PF). Repetitive damage...
Autores principales: | Hirawat, Rishabh, Jain, Namrata, Aslam Saifi, Mohd, Rachamalla, Mahesh, Godugu, Chandraiah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633631/ https://www.ncbi.nlm.nih.gov/pubmed/36736220 http://dx.doi.org/10.1016/j.intimp.2022.109418 |
Ejemplares similares
-
Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications
por: Hirawat, Rishabh, et al.
Publicado: (2021) -
COVID-19 and fibrosis: Mechanisms, clinical relevance, and future perspectives
por: Saifi, Mohd Aslam, et al.
Publicado: (2022) -
Inhibition of discoidin domain receptors by imatinib prevented pancreatic fibrosis demonstrated in experimental chronic pancreatitis model
por: Bansod, Sapana, et al.
Publicado: (2021) -
Novel Methods and Approaches for Safety Evaluation of Nanoparticle Formulations: A Focus Towards In Vitro Models and Adverse Outcome Pathways
por: Tirumala, Mounika Gayathri, et al.
Publicado: (2021) -
The current understanding and potential therapeutic options to combat COVID-19
por: Pooladanda, Venkatesh, et al.
Publicado: (2020)